IDXG Projected Dividend Yield
Com Par $0.01/Interpace Biosciences Inc ( OTCBB : IDXG )Interpace Biosciences engages in oncology by providing services from early diagnosis and prognostic planning to targeted therapeutic applications through its clinical and pharma services. Co.'s commercialized molecular diagnostic tests include: PancraGEN®, which is a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians assess risk of pancreaticobiliary cancers using its PathFinderTG® platform; and PanDNA, a molecular only version of PancraGEN® that provides physicians a snapshot of a limited number of factors. Through its pharma services, Co. provides ancillary services, including: biorepository, clinical trial logistics, and clinical trial design. 20 YEAR PERFORMANCE RESULTS |
IDXG Dividend History Detail IDXG Dividend News IDXG Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |